ask="32.13"
ask_size="100"
average_daily_volume="220575"
bid="N/A"
bid_size="N/A"
book_value="3.79"
change="+1.32"
change_from_200_day_moving_average="6.63"
change_from_50_day_moving_average="4.41"
change_from_52_week_high="-0.17"
change_From_52_week_low="18.01"
change_in_percent="+4.28%"
close="32.13"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-2.97"
ex_dividend_date="N/A"
float_shares="15631000"
high="32.18"
high_52_weeks="32.30"
last_trade_date="3/3/2017"
last_trade_price="32.13"
last_trade_size="11796"
last_trade_time="4:00pm"
low="30.43"
low_52_weeks="14.12"
market_capitalization="688.61M"
moving_average_200_day="25.50"
moving_average_50_day="27.72"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="30.73"
pe_ratio="N/A"
peg_ratio="-0.22"
percent_change_from_200_day_moving_average="+26.01%"
percent_change_from_50_day_moving_average="+15.91%"
percent_change_from_52_week_high="-0.53%"
percent_change_from_52_week_low="+127.55%"
previous_close="30.81"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.14"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.47"
stock_exchange="NMS"
symbol="ACRS"
volume="215884"
weeks_range_52="14.12 - 32.30"
